You are now leaving the Kedrion Corporate site. The information available in your chosen website may not be in compliance with EU legislation regulating the advertising of medicinal products for human use, nor do the opinions expressed necessarily reflect the Company’s positions or are endorsed by it.
NO
YES
  1. EVENTS - 10-04-2018

    50-Year Anniversary of a Maternal Health Breakthrough

    Kedrion Biopharma supports session on Anti-D achievements and challenges at FIGO Congress in Dubai

    read more 
  2. CORPORATE - 16-02-2018

    Kedrion Biopharma runner up at the Premio Equita for the bond issued in July 2017

    The prize is awarded to the companies that made the best use of the capital markets

    read more 
  3. EVENTS - 14-02-2018

    Kedrion Biopharma joins Columbia University to celebrate 50 years of Anti-D

    Since 1968, billions of babies have been saved from Hemolytic Disease of the Fetus and Newborn

    read more 
  4. CORPORATE - 10-01-2018

    Hemophilia: Kedrion signs on to groundbreaking PARTNERS programme

    Goal is to improve access to replacement therapies for coagulation disorders in Europe

    read more 

Pages

For more information please contact: pressoffice@kedrion.com